Navigation Links
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
Date:2/23/2009

p://www.americanheart.org/downloadable/heart/1200082005246HS_Stats%202008.final.pdf. Accessed December 9, 2008.

(3) WebMD Medical Reference in Collaboration with the Cleveland Clinic. Heart Disease: Coronary Artery Disease. http://www.webmd.com/heart-disease/guide/heart-disease-coronary-artery-disease. Accessed December 9, 2008.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains certain forward-looking statements about the potential of prasugrel (CS-747, LY640315) and reflects Daiichi Sankyo's and Lilly's current beliefs. However, as with any pharmaceutical compound, there are substantial risks and uncertainties in the process of development, regulatory review, and commercialization. There is no guarantee that the compound will receive regulatory approvals, that the regulatory approvals will be for the indication(s) anticipated by the companies, or that later studies and patient experience will be consistent with study findings to date. There is also no guarantee that the compound will prove to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filing with the United States Securities and Exchange Commission and Daiichi Sankyo's filings with the Tokyo<
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
2. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
3. Registration Open for OpenClinica European Summit - April 14, 2009
4. Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project
5. Myngle Best ICT Company at the European Ventures Summit
6. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
7. Kuvan Receives Marketing Approval in the European Union
8. BioLife Solutions Granted European Biopreservation Patent
9. European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report
10. Vicenza Hospital Becomes First European Facility to Purchase Its Second CyberKnife System
11. Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... level storage is now available to small and mediu... bank. , (PRWEB) December...), a medical imaging software company, announced t... service. The PacsDrive service enables small and ...hive medical imaging in compliance with HIPAA regu...
(Date:12/1/2009)... 1 Aethlon Medical, Inc....t will present at the LD MICRO Conference on Thurs...xe Hotel in Los Angeles. Aethlon Medical,s Chairma...e overview and will provide an update on the compa...emopurifier®, a first-in-class artificial adj...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- Medizone International, I...t in tests involving its proprietary AsepticSure(T...tamination barriers, this time with two very diffe...e and Bacillis subtilis. These results clearly est...icidal technology. "The implications of a 6.7 log ...
(Date:12/1/2009)...ical study presented to the American Society for R...(3-D) automated ultrasound follicle measurement us...lization (IVF) cycle is effective and more efficie...icles. , Gurnee, IL (PRWE...er of Chicago has just completed research on a new...
Breaking Biology Technology:PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3
... Veteran Richard Franco and Entrepreneur Anthony ...ectors, IRVINE, Calif., Sept. 5 NeoMatrix, devel...tomatic, noninvasive test designed to,identify bre...has closed a,Series C round of equity financing. T...e of the HALO System, which is designed to test as...
...na Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced... the Bear Stearns 20th Annual Healthcare Conferenc...(12:30 p.m. Pacific Time) at the Grand,Hyatt Hotel...d Chief,Executive Officer, is scheduled to provide...cal development and discovery programs. A live au...
... the Key Problems Faced by Insomniacs, i.e.,Sleep ...erence Call Today at 11:00 am CET (10:00 am UK,tim...rldsleep07 Congress in,Australia HAMBURG, Germany...kfurt Stock Exchange: EVT),presented today at the ...ails of the results from its first Phase II clinic...
Other Biology Technology:NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 2NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 3NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 4Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 3Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201 2Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201 3Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201 4
(Date:12/1/2009)...y-led international research team has developed an...neration of solar cells. , Scientists at Monash ...the universities of Wollongong and Ulm in Germany,...ith a three-fold increase in energy conversion eff...ye-sensitised solar cells. , Lead researcher Dr...
(Date:12/1/2009)... to the radio anymore. They,re used in everything ...th Carolina State University is revolutionizing th... antennas that open the door to a host of new uses...deployment. , Modern antennas are made from copp...ow far they can be bent and how often before the...
(Date:11/30/2009)...e state of Antarctica,s climate and its relationsh...week (Tuesday 1 December) by the Scientific Commit...tarctic Climate Change and the Environment presen...ntifies areas for future scientific research, and ...have about Antarctic melting, sea-level rise and b...
Breaking Biology News(10 mins):Innovation puts next-generation solar cells on the horizon 2Shape shifters: Researchers create new breed of antennas 2First comprehensive review of the state of Antarctica's climate 2Express Scripts Launches Senior Notes Offering to Finance Acquisition 47927 1Express Scripts Launches Senior Notes Offering to Finance Acquisition 47927 2Express Scripts Launches Senior Notes Offering to Finance Acquisition 47927 3Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 1Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 2Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 3Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 4Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 5Albertsons LLC Selects PDX NHIN Rx com to Provide Complete Pharmacy Management Solution 47921 1Albertsons LLC Selects PDX NHIN Rx com to Provide Complete Pharmacy Management Solution 47921 2
...the growth and development of plants, but what eff...aper by Nathalie Hoang et al., published in PLoS ...ining cryptochromes in flies, mice, and humans. In...which absorb and process blue light for functions ... stem expansion. Cryptochromes are present in huma...
...--In a breakthrough scientific study published tod...Sciences , scientists at the Burnham Institute for... development may be linked to Autism. The study de...factor 2C (MEF2C) protein in neural stem cells had...viors similar to those seen in humans with a form ...
...move that promises to change the economics of biod...ity have unveiled a set of techniques for cleanly ...ls that fetch a profit. , The latest research is ...ring . The new paper and others published earlier ... allows E. coli and other enteric bacteria to co...
Other Biology News:A mammalian clock protein responds directly to light 2Researchers link early stem cell mutation to autism 2Research yields pricey chemicals from biodiesel waste 2Research yields pricey chemicals from biodiesel waste 3
...terials necessary for the isolation and preparatio...lysis. Kit Components: Erythrocyte Lysis Buff...mL of buffered ammonium chloride. (NH 4 Cl) Fixat...containing 220 mL of PBS, formalin, sucrose and 0....
Rabbit Anti-NO-TRYPTOPHAN CONJUGATE Polyclonal Antibody, Unconjugated from AbD Serotec
Goat Anti-Human SLI Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-L-DIHYDROXYPHENYLALANINE (L-DOPA) CONJUGATE Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: